SI2121716T1 - Sestavki stabilnih tiakumicinov - Google Patents

Sestavki stabilnih tiakumicinov

Info

Publication number
SI2121716T1
SI2121716T1 SI200831576T SI200831576T SI2121716T1 SI 2121716 T1 SI2121716 T1 SI 2121716T1 SI 200831576 T SI200831576 T SI 200831576T SI 200831576 T SI200831576 T SI 200831576T SI 2121716 T1 SI2121716 T1 SI 2121716T1
Authority
SI
Slovenia
Prior art keywords
tiacumicins
compositions
stable
stable tiacumicins
Prior art date
Application number
SI200831576T
Other languages
English (en)
Inventor
Suketu Sanghvi
Mark Roach
Joseph F. Zhou
Ping He
Michael Mittleberg
Original Assignee
Merck Sharp & Dohme Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp. filed Critical Merck Sharp & Dohme Corp.
Publication of SI2121716T1 publication Critical patent/SI2121716T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200831576T 2007-01-19 2008-01-17 Sestavki stabilnih tiakumicinov SI2121716T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88113707P 2007-01-19 2007-01-19
EP08724557.7A EP2121716B1 (en) 2007-01-19 2008-01-17 Compositions of stable tiacumicins
PCT/US2008/000591 WO2008091518A1 (en) 2007-01-19 2008-01-17 Compositions of stable tiacumicins

Publications (1)

Publication Number Publication Date
SI2121716T1 true SI2121716T1 (sl) 2016-03-31

Family

ID=39641896

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831576T SI2121716T1 (sl) 2007-01-19 2008-01-17 Sestavki stabilnih tiakumicinov

Country Status (22)

Country Link
US (2) US20080176927A1 (sl)
EP (1) EP2121716B1 (sl)
JP (2) JP5635266B2 (sl)
KR (1) KR101491729B1 (sl)
CN (2) CN102015747A (sl)
BR (1) BRPI0806713A8 (sl)
CA (1) CA2676003C (sl)
CY (1) CY1117237T1 (sl)
DK (1) DK2121716T3 (sl)
ES (1) ES2560669T3 (sl)
HR (1) HRP20151438T1 (sl)
HU (1) HUE028671T2 (sl)
IL (1) IL199941A (sl)
MX (1) MX2009007784A (sl)
NZ (1) NZ578493A (sl)
PL (1) PL2121716T3 (sl)
PT (1) PT2121716E (sl)
RU (1) RU2484829C2 (sl)
SI (1) SI2121716T1 (sl)
TW (1) TWI474820B (sl)
WO (1) WO2008091518A1 (sl)
ZA (1) ZA200905134B (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
AU2011255630B2 (en) * 2010-05-18 2015-04-30 Merck Sharp & Dohme Llc Treatment of Clostridium difficile infection in patients undergoing antibiotic therapy
CA2799531A1 (en) * 2010-05-18 2011-11-24 Optimer Pharmaceuticals, Inc. Treating recurring clostridium difficile infection using fidaxomicin
CN105287473A (zh) * 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
CA2826662A1 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
ITMI20120560A1 (it) 2012-04-05 2013-10-06 Olon Spa Procedimento per la purificazione della tiacumicina b
JO3464B1 (ar) * 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
US20150141356A1 (en) * 2013-11-15 2015-05-21 Optimer Pharmaceuticals, Inc. Treatment of Clostridium Difficile Infection in High Risk Patients
WO2015127955A1 (en) 2014-02-25 2015-09-03 Olon S.P.A. A new polymorph of tiacumicin b and process for preparation thereof
US10137141B2 (en) * 2014-05-09 2018-11-27 Astellas Pharma Europe Ltd. Treatment regimen tiacumicin compound
CN110037992B (zh) * 2019-05-28 2021-05-28 杭州华东医药集团新药研究院有限公司 一种稳定的非达霉素组合物
CN112353774B (zh) * 2020-11-17 2022-08-23 浙江汇能生物股份有限公司 一种那西肽风味咀嚼片及其制备方法及其在犬魏氏梭菌病上的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05192094A (ja) * 1991-09-03 1993-08-03 Takeda Chem Ind Ltd 造粒組成物
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
WO2002032427A1 (en) * 2000-10-20 2002-04-25 Galephar M/F Stable oral formulation containing benzimidazole derivative
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
JP2005534332A (ja) * 2002-07-29 2005-11-17 オプティマー ファーマシューティカルズ、インコーポレイテッド チアクマイシン生産
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
JP5166040B2 (ja) * 2005-01-31 2013-03-21 オプティマー ファーマシューティカルズ、インコーポレイテッド 18員大環状化合物及びその類似化合物

Also Published As

Publication number Publication date
BRPI0806713A2 (pt) 2011-09-13
TWI474820B (zh) 2015-03-01
EP2121716A1 (en) 2009-11-25
NZ578493A (en) 2012-02-24
CN105169396A (zh) 2015-12-23
HUE028671T2 (en) 2016-12-28
DK2121716T3 (en) 2016-03-14
EP2121716B1 (en) 2015-12-09
CA2676003A1 (en) 2008-07-31
RU2484829C2 (ru) 2013-06-20
TW200938187A (en) 2009-09-16
HRP20151438T1 (hr) 2016-01-29
IL199941A0 (en) 2010-04-15
JP2014205701A (ja) 2014-10-30
EP2121716A4 (en) 2013-06-12
JP5635266B2 (ja) 2014-12-03
AU2008209623A1 (en) 2008-07-31
CN102015747A (zh) 2011-04-13
KR101491729B1 (ko) 2015-02-09
ES2560669T3 (es) 2016-02-22
US20080176927A1 (en) 2008-07-24
BRPI0806713A8 (pt) 2017-04-18
ZA200905134B (en) 2013-08-28
IL199941A (en) 2016-02-29
PT2121716E (pt) 2016-03-03
US20130065844A1 (en) 2013-03-14
KR20090107061A (ko) 2009-10-12
CA2676003C (en) 2012-04-10
WO2008091518A1 (en) 2008-07-31
JP5995331B2 (ja) 2016-09-21
CY1117237T1 (el) 2017-04-05
AU2008209623A2 (en) 2010-01-28
RU2009128612A (ru) 2011-02-27
JP2010516677A (ja) 2010-05-20
MX2009007784A (es) 2010-02-11
PL2121716T3 (pl) 2016-04-29

Similar Documents

Publication Publication Date Title
ZA201103926B (en) Stable sulfoximine-insecticide compositions
ZA200905134B (en) Compositions of stable tiacumicins
EP2219637A4 (en) AVENANTHRAMIDE COMPOSITIONS
IL199656A0 (en) Tablet-in-tablet compositions
GB0724342D0 (en) Anitbacterial compositions
HUE059171T2 (hu) Kompozíciók
PT2634232T (pt) Composições
GB0810404D0 (en) Compositions
GB0711683D0 (en) Compositions
GB0712024D0 (en) Compositions
HK1159668A1 (en) Multi-cure compositions
GB0812041D0 (en) Compositions
GB0808537D0 (en) Compositions
GB0818804D0 (en) Compositions
GB0713707D0 (en) Stable compositions
ZA201002504B (en) Novel taxoid-based compositions
EP2214697A4 (en) COMPOSITIONS OF NELL-1
GB0723803D0 (en) Compositions
GB0710108D0 (en) Compositions
GB0712043D0 (en) Compositions
GB0700477D0 (en) Compositions
GB0713261D0 (en) Compositions
GB0703964D0 (en) Compositions
GB0706047D0 (en) Anit-viral compositions
GB0711689D0 (en) Compositions